Natural Hair 5 alpha reductase acne androgenetic BPH cortex anti androgen diffuse alopecia finasteride propecia androcur cypreoterone acetate antiandrogens Alopecia and Hair loss resource center. An information site providing information to help assist people suffering from hair loss.
Natural HairFrequently Asked Questions
Links to other SitesPrivacy Policy
Search ....  
UK SITE
View your shopping cart

Dutas
Propecia
Proscar
Regaine 5%
Headway
Nizoral Shampoo
Prostaguard
Retin-A
Skinoren
Pill Cutter

Hairloss information and resources
provided
by Natural-Hair
Hair Structure and Life Cycle
Common Types of Hair Loss
Alopecia Areata
Androgenetic Alopecia
Anagen Effluvium
Self Induced Hair Loss
Scarring Alopecia
Other Types of Hair Loss
Hair Loss Treatments
Medical Treatments for Androgenetic Alopecia
Natural Treatments for Androgenetic Alopecia
Alopecia Areata Treatments
Glossary of terms
Links to other sites
E-mail Enquiries/ Comments
        
Home Inhouse Drugstore
 
 
  Clinical applications of antiandrogens. 62 REFS

TITLE
Clinical applications of antiandrogens. 62 REFS

AUTHOR
Namer M

ORGANIATION
Centre Antoine-Lacassagne, Nice, France.

SOURCE
J Steroid Biochem 1988 Oct; 31 (4B): 719-29

LANGUAGE OF PUBLICATION
English

ABSTRACT
Antiandrogens, substances that prevent androgens from expressing their activity at target cells, play an important role in the treatment of prostate cancer. The most frequently used substances have either a steroidal structure (cyproterone acetate) or a non-steroidal structure (Flutamide or Anandron). Antiandrogens have been tested both alone and in combination with treatments aimed at inhibiting testicular secretion (castration, LH-RH analogs), thereby producing complete blockade of androgen secretion and action. Patients treated by such combination protocols have often shown an improvement in the percentage of remissions and, less often, improvement in survival. Administration of antiandrogens improves the clinical symptoms of patients with benign prostatic hypertrophy, but the exact mechanism of their action requires further investigation. Cutaneous manifestations due to hyperandrogenicity (hirsutism, alopecia, acne) have also been improved by cyproterone acetate, which is often given together with estrogens (reversed sequential regime), by spironolactone or topically applied products. Finally, antiandrogens have been successfully used to treat breast cancer in men, early puberty, hypersexuality and sexual deviations. (AUTHOR)

MJTR: Androgen Antagonists TU. Breast Neoplasms DT. Prostatic Hyperplasia DT. Prostatic Neoplasms DT. Skin Diseases DT.

MNTR: Cyproterone AA. Cyproterone TU. Female. Flutamide TU. Human. Imidazoles TU. Male. Puberty, Precocious DT. Spironolactone TU. JOURNAL ARTICLE. REVIEW. REVIEW, TUTORIAL

RNUM: 0 (Androgen Antagonists); 0 (Imidazoles); 13311-84-7 (Flutamide); 2098-66-0 (Cyproterone); 427-51-0 (Cyproterone Acetate); 52-01-7 (Spironolactone); 63612-50-0 (nilutamide)

GEOT: ENGLAND

IDEN: ISSN: 0022-4731. JOURNAL-CODE: K70. ENTRY-DATE: 890119. JOURNAL-SUBSET: M X. IM-DATE: 8903.

ACCE: 89069561